Get the app!
Back to Trades
Grant4

VERTEX PHARMACEUTICALS INC / MA

VRTX

Total Value
$0

Company Information

Ticker Symbol
VRTX
CIK
0000875320

Insider Information

Role
EVP and CMO
Officer
Location
BOSTON, MA

Filing Details

Filing Date
Jan 26, 2026
Transaction Date
Jan 22, 2026
Accession Number
0000875320-26-000016
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Jan 22, 2026Common Stock7,866Grant/Award
Jan 22, 2026Common Stock3,467Grant/Award

Footnotes

  1. (F1)Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 01/22/2026 and the shares will vest on 02/13/2026.
  2. (F2)Represents earned performance shares with respect to a performance stock unit award granted on 02/12/2025 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 01/22/2026 and the shares will vest in installments beginning on 02/24/2026.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.